NiKang Therapeutics
Organisation
Trials
Phase 1, Recruiting, 361 people, 19 Jun 2025
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Phase 1, Recruiting, 238 people, 19 Sept 2024
Phase 2, Terminated, 18 people, 7 Jul 2023
Collaborator, Phase 1/2, Active, not recruiting, 518 people, 24 Aug 2020
Sources: clinicaltrials.gov
Deals with
Licence, 3 May 2022
Sources: www1.hkexnews.hk